CDKN2A Antikörper (AA 8-156)
-
- Target Alle CDKN2A Antikörper anzeigen
- CDKN2A (Cyclin-Dependent Kinase Inhibitor 2A (Melanoma, P16, Inhibits CDK4) (CDKN2A))
-
Bindungsspezifität
- AA 8-156
-
Reaktivität
- Human
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser CDKN2A Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB), Immunohistochemistry (IHC), Immunoprecipitation (IP), Immunocytochemistry (ICC)
- Verwendungszweck
- Polyclonal Antibody to Cyclin Dependent Kinase Inhibitor 2A (CDKN2A)
- Spezifität
- The antibody is a rabbit polyclonal antibody raised against CDKN2A. It has been selected for its ability to recognize CDKN2A in immunohistochemical staining and western blotting.
- Kreuzreaktivität
- Maus
- Aufreinigung
- Antigen-specific affinity chromatography followed by Protein A affinity chromatography
- Immunogen
- Recombinant Cyclin Dependent Kinase Inhibitor 2A (CDKN2A) corresdonding to Ser8~Asp156 with N-terminal His Tag
- Isotyp
- IgG
-
-
- Applikationshinweise
-
Western blotting: 0.5-2 μg/mL
Immunohistochemistry: 5-20 μg/mL
Immunocytochemistry: 5-20 μg/mL
Optimal working dilutions must be determined by end user.
- Kommentare
-
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37°C for 48h, and no obvious degradation and precipitation were observed. The loss rate is less than 5% within the expiration date under appropriate storage condition.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Buffer
- 0.01M PBS, pH 7.4, containing 0.05 % Proclin-300, 50 % glycerol.
- Konservierungsmittel
- ProClin
- Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- 4 °C,-20 °C
- Informationen zur Lagerung
- Store at 4°C for frequent use. Stored at -20°C in a manual defrost freezer for two year without detectable loss of activity. Avoid repeated freeze-thaw cycles.
- Haltbarkeit
- 24 months
-
- Target
- CDKN2A (Cyclin-Dependent Kinase Inhibitor 2A (Melanoma, P16, Inhibits CDK4) (CDKN2A))
- Andere Bezeichnung
- Cyclin Dependent Kinase Inhibitor 2A (CDKN2A Produkte)
- Synonyme
-
Arf antikoerper, p16 antikoerper, MTS1 antikoerper, INK4A antikoerper, p19ARF antikoerper, p16Cdkn2a antikoerper, ARF antikoerper, CDK4I antikoerper, CDKN2 antikoerper, CMM2 antikoerper, INK4 antikoerper, MLM antikoerper, MTS-1 antikoerper, P14 antikoerper, P14ARF antikoerper, P16 antikoerper, P16-INK4A antikoerper, P16INK4 antikoerper, P16INK4A antikoerper, P19 antikoerper, P19ARF antikoerper, TP16 antikoerper, ARF-INK4a antikoerper, INK4a-ARF antikoerper, Ink4a/Arf antikoerper, Pctr1 antikoerper, p16(INK4a) antikoerper, p16INK4a antikoerper, p19
antikoerper, cyclin-dependent kinase inhibitor 2A antikoerper, cyclin dependent kinase inhibitor 2A antikoerper, Cdkn2a antikoerper, LOC100731972 antikoerper, LOC100340625 antikoerper, CDKN2A antikoerper - Hintergrund
- P16, ARF, CDK4I, CMM2, INK4, INK4a, MLM, MTS1, TP16, P14, P14ARF, P16INK4a, P19, Melanoma P16, Cyclin-dependent kinase 4 inhibitor A, Multiple tumor suppressor 1
- Pathways
- Mitotic G1-G1/S Phases, Stem Cell Maintenance, Positive Regulation of Endopeptidase Activity, Autophagie, Positive Regulation of Response to DNA Damage Stimulus
-